Search research articles
Contact Us
Filters
Showing results (141-150 of 199) with videos related to
Page
of 20
Sort By:
Future Oncology (London, England)
|
July 31, 2024
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer
David M O'Malley, Tashanna Myers, Pauline Wimberger, et al.
The Science of the Total Environment
|
April 2, 2020
When archives are missing, deciphering the effects of public policies and climate variability on the Brazilian semi-arid region using sediment core studies
Marie-Pierre Ledru, Vivian Jeske-Pieruschka, Laurent Bremond, et al.
Bulletin Du Cancer
|
December 17, 2024
[A 2024 inventory in oncology news]
Stéphane Vignot, Audrey Bellesoeur, Carole Bouleuc, et al.
American Journal of Human Genetics
|
December 2, 2022
Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor
Anne-Céline Derrien, Alexandre Houy, Olivier Ganier, et al.
JAMA Ophthalmology
|
April 30, 2026
Prevalence of the Predisposing Gene MBD4 for Uveal Melanoma
Anaïs Le Ven, Marie-Charlotte Villy, Marine Le Mentec, et al.
Ophthalmology Science
|
December 11, 2025
Genetic Background Predicts Uveal Melanoma Patients' Outcomes
Thibault Verrier, Anaïs Le Ven, Alexandre Houy, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 7, 2022
L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases
Raymond Barnhill, Steven van Laere, Peter Vermeulen, et al.
JCO Precision Oncology
|
May 24, 2023
Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma
Stéphane Champiat, Hélène Salaün, Francesca Lucibello, et al.
Annals of Surgery
|
February 27, 2023
Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma
Pascale Mariani, François-Clément Bidard, Aurore Rampanou, et al.
NPJ Precision Oncology
|
November 3, 2022
Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency
Thomas Chabot, Fariba Nemati, Aurélie Herbette, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 199) with videos related to
Sort By:
Page
of 20
Future Oncology (London, England)
|
July 31, 2024
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer
David M O'Malley, Tashanna Myers, Pauline Wimberger, et al.
The Science of the Total Environment
|
April 2, 2020
When archives are missing, deciphering the effects of public policies and climate variability on the Brazilian semi-arid region using sediment core studies
Marie-Pierre Ledru, Vivian Jeske-Pieruschka, Laurent Bremond, et al.
Bulletin Du Cancer
|
December 17, 2024
[A 2024 inventory in oncology news]
Stéphane Vignot, Audrey Bellesoeur, Carole Bouleuc, et al.
American Journal of Human Genetics
|
December 2, 2022
Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor
Anne-Céline Derrien, Alexandre Houy, Olivier Ganier, et al.
JAMA Ophthalmology
|
April 30, 2026
Prevalence of the Predisposing Gene MBD4 for Uveal Melanoma
Anaïs Le Ven, Marie-Charlotte Villy, Marine Le Mentec, et al.
Ophthalmology Science
|
December 11, 2025
Genetic Background Predicts Uveal Melanoma Patients' Outcomes
Thibault Verrier, Anaïs Le Ven, Alexandre Houy, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 7, 2022
L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases
Raymond Barnhill, Steven van Laere, Peter Vermeulen, et al.
JCO Precision Oncology
|
May 24, 2023
Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma
Stéphane Champiat, Hélène Salaün, Francesca Lucibello, et al.
Annals of Surgery
|
February 27, 2023
Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma
Pascale Mariani, François-Clément Bidard, Aurore Rampanou, et al.
NPJ Precision Oncology
|
November 3, 2022
Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency
Thomas Chabot, Fariba Nemati, Aurélie Herbette, et al.
Page
of 20